Ralph N. Martins
Cited by
Cited by
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
RJ Bateman, C Xiong, TLS Benzinger, AM Fagan, A Goate, NC Fox, ...
New England Journal of Medicine 367 (9), 795-804, 2012
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
The Lancet Neurology 12 (4), 357-367, 2013
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
A Nakamura, N Kaneko, VL Villemagne, T Kato, J Doecke, V Doré, ...
Nature 554 (7691), 249-254, 2018
Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.
CL Masters, G Multhaup, G Simms, J Pottgiesser, RN Martins, ...
The EMBO journal 4 (11), 2757-2763, 1985
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ...
Neurobiology of aging 31 (8), 1275-1283, 2010
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ...
Annals of neurology 69 (1), 181-192, 2011
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of …
KA Ellis, AI Bush, D Darby, D De Fazio, J Foster, P Hudson, ...
International psychogeriatrics 21 (4), 672-687, 2009
Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease
B Rumble, R Retallack, C Hilbich, G Simms, G Multhaup, R Martins, ...
New England Journal of Medicine 320 (22), 1446-1452, 1989
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ...
Nature medicine 25 (2), 277-283, 2019
Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor
L Xie, E Helmerhorst, B Plewright, W Van Bronswijk, R Martins
The Journal of Neuroscience 22 (RC221), 1-5, 2002
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis
DC Ryman, N Acosta-Baena, PS Aisen, T Bird, A Danek, NC Fox, A Goate, ...
Neurology 83 (3), 253-260, 2014
A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic …
L Davies, B Wolska, C Hilbich, G Multhaup, R Martins, G Simms, ...
Neurology 38 (11), 1688-1688, 1988
White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network
S Lee, F Viqar, ME Zimmerman, A Narkhede, G Tosto, TLS Benzinger, ...
Annals of neurology 79 (6), 929-939, 2016
Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease
IJ Martins, E Hone, JK Foster, SI Sünram-Lea, A Gnjec, SJ Fuller, D Nolan, ...
Molecular psychiatry 11 (8), 721-736, 2006
Blood-based protein biomarkers for diagnosis of Alzheimer disease
JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ...
Archives of neurology 69 (10), 1318-1325, 2012
Increased risk of cognitive impairment in patients with diabetes is associated with metformin
EM Moore, AG Mander, D Ames, MA Kotowicz, RP Carne, H Brodaty, ...
Diabetes care 36 (10), 2981-2987, 2013
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ...
Annals of neurology 67 (3), 317-324, 2010
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ...
Nature medicine 26 (3), 398-407, 2020
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease
A Maczurek, K Hager, M Kenklies, M Sharman, R Martins, J Engel, ...
Advanced drug delivery reviews 60 (13-14), 1463-1470, 2008
The system can't perform the operation now. Try again later.
Articles 1–20